Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Histogen Inc. (HSTO)

1.5   0.05 (3.45%) 09-29 00:51
Open: 1.42 Pre. Close: 1.45
High: 1.58 Low: 1.42
Volume: 38,734 Market Cap: 18M
Histogen Inc., formerly Conatus Pharmaceuticals Inc., is a regenerative medicine company. The Company is focused on developing technologies that replace and regenerates tissues in the body. The company’s technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address unmet medical needs. The Company has product candidates in clinical development intended to address and offer treatment for hair loss, dermal filler and treatment for joint cartilage repair. The Company manufactures a soluble multipotent cell conditioned media (CCM), which is the starting material for products for hair growth, skin care and other applications. In addition to this, the Company also manufactures an insoluble extracellular matrix (ECM) for applications such as orthopedics, wound care and soft tissue augmentation.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.581 - 1.589 1.589 - 1.596
Low: 1.403 - 1.411 1.411 - 1.418
Close: 1.487 - 1.5 1.5 - 1.512

Technical analysis

as of: 2020-09-28 4:33:39 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 2.12     One year: 2.50
Support: Support1: 1.30    Support2: 1.08
Resistance: Resistance1: 1.82    Resistance2: 2.14
Pivot: 1.61
Moving Average: MA(5): 1.49     MA(20): 1.67
MA(100): 2.64     MA(250):
MACD: MACD(12,26): -0.22     Signal(9): -0.23
Stochastic oscillator: %K(14,3): 21.14     %D(3): 13.69
RSI: RSI(14): 29.00
52-week: High: 5.26  Low: 0.23  Change(%): 328.6
Average Vol(K): 3-Month: 11590  10-Days: 37616

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
HSTO has closed above bottom band by 22.4%. Bollinger Bands are 75.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to HSTO's normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 17 Sep 2020
Histogen Inc. (NASDAQ:HSTO) Stock is Soaring, Here is Why - The Oracle Dispatch

Thu, 17 Sep 2020
Histogen Inc. (HSTO) is on the roll with an average volume of 55.93K in the recent 3 months - The InvestChronicle

Thu, 17 Sep 2020
Histogen Inc. (HSTO) volume hits 2.95 million: A New Opening for Investors - News Daemon

Wed, 16 Sep 2020
Histogen Announces $2M Grant Award from the Department of Defense for Clinical Advancement of HST-003 for Cartilage Regeneration in the Knee - GlobeNewswire

Wed, 16 Sep 2020
Histogen Inc. (NASDAQ:HSTO) stock sentiment check: What does Wall Street Say? - Stocks Register

Wed, 16 Sep 2020
Histogen Inc. (HSTO) Announces $2M Grant Award from the Department of Defense for Clinical Advancement of HST-003 for Cartilage Regeneration in the Knee - StreetInsider.com

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 12
Shares Float (M) 8
% Held by Insiders
% Held by Institutions
Shares Short (K) 30
Shares Short P. Month (K) 55

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -384.47
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth -92.4
Gross Profit (p.s.) 0.251
Sales Per Share 0.242
EBITDA (p.s.) -0.922
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 6.19
Price to Cash Flow -2.19

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.